Seroprevalence of the hepatitis C virus in donors and in high and low risk groups in Salamanca
Martín, A.M.; Canut, A.; Corral, M.; Cordero, M.
Medicina Clinica 98(17): 676-677
1992
ISSN/ISBN: 0025-7753 PMID: 1598016 Document Number: 391336
Document emailed within 1 workday
Related Documents
Pár, A. 1991: Incidence of hepatitis C virus antibodies in blood donors, high risk patient groups, liver diseases and health professionals. Multicenter study of the ABBOT ELISA method, comparison with the ORTHO test Orvosi Hetilap 132(18): 955-959Ruzibakiev, R.; Kato, H.; Ueda, R.; Yuldasheva, N.; Hegay, T.; Avazova, D.; Kurbanov, F.; Zalalieva, M.; Tuichiev, L.; Achundjanov, B.; Mizokami, M. 2001: Risk factors and seroprevalence of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infection in uzbekistan Intervirology 44(6): 327-332
Jutavijittum, P.; Yousukh, A.; Samountry, B.; Samountry, K.; Ounavong, A.; Thammavong, T.; Keokhamphue, J.; Toriyama, K. 2007: Seroprevalence of hepatitis B and C virus infections among Lao blood donors Southeast Asian Journal of Tropical Medicine and Public Health 38(4): 674-679
Nijhawan, S.; Vijayvergiya, R.; Agrawal, S.; Jain, S.; Rai, R.R. 1997: Seroprevalence of hepatitis C virus in various groups living in captivity Indian Journal of Gastroenterology: Official Journal of the Indian Society of Gastroenterology 16(2): 75-76
Halim, N.K.; Ajayi, O.I. 2000: Risk factors and seroprevalence of hepatitis C antibody in blood donors in Nigeria East African Medical Journal 77(8): 410-412
Mikhaylov, M.I.; Mamedov, M.K.; Dadasheva, A.E. 2015: Viral indicators of the increased epidemiological hazard of subjects from high risk groups of hepatitis C virus parenteral infection Voprosy Virusologii 60(2): 38-40
Celen, M.K.; Ayaz, C.; Hosoglu, S.; Geyik, M.F.; Ulug, M. 2006: Anti-hepatitis delta virus seroprevalence and risk factors in patients with hepatitis B in Southeast Turkey Saudi Medical Journal 27(5): 617-620
Kumari, S.; Rai, A.; Chattopadhya, D.; Khare, S.; Ichhpujani, R.L.; Sehgal, P.N. 1986: Screening for seroprevalence of HTLV-III/HIV infection in high risk groups in Delhi Journal of Communicable Diseases 18(2): 77-80
Kumari, S.; Rai, A.; Chattopadhya, D.; Khare, S.; Ichhpujani, R.L.; Sehgal, P.N. 1986: Screening for seroprevalence of HTLV-III/HIV infection in high risk groups in Delhi Journal of Communicable Diseases 18(2): 77-80
Li, N.; Wang, Z.; Sun, D.; Zhu, Q.; Sun, G.; Yang, W.; Wang, Q.; Nie, Y.; Wu, Z. 2010: HIV among plasma donors and other high-risk groups in Henan, China Journal of Acquired Immune Deficiency Syndromes 53(Suppl 1): S41-S47
Ilami, O.; Sarkari, B.; Khosravani, A.; Tori, M.A.; Hosseini, Z. 2012: HIV seroprevalence among high-risk groups in Kohgiloyeh and Boyerahmad Province, Southwest of Iran, a behavioral surveillance survey Aids and Behavior 16(1): 86-90
Rudra, S.; Chakrabarty, P.; Hossain, M.A.; Akhter, H.; Bhuiyan, M.R. 2010: Seroprevalence of Hepatitis B, Hepatitis C, HIV Infections in Blood Donors of Khulna, Bangladesh Mymensingh Medical Journal: Mmj 19(4): 515-519
Chiarakul, S.; Eunumjitkul, K.; Vuttiopas, S.; Vorapimol, A-Reerut.; Kaewkungwal, J.; Poovorawan, Y. 2007: Seroprevalence and risk factors of hepatitis B virus infection among health care workers at the Institute of Neurology Journal of the Medical Association of Thailand 90(8): 1536-1545
Pouliquen, J.-F.ço.; Hardy, L.; Lavergne, A.; Kafiludine, E.; Kazanji, M. 2004: High seroprevalence of human T-cell lymphotropic virus type 1 in blood donors in Guyana and molecular and phylogenetic analysis of new strains in the Guyana shelf (Guyana, Suriname, and French Guiana) Journal of Clinical Microbiology 42(5): 2020-2026
Pouliquen, J.-F.ço.; Hardy, L.; Lavergne, A.; Kafiludine, E.; Kazanji, M. 2004: High seroprevalence of human T-cell lymphotropic virus type 1 in blood donors in Guyana and molecular and phylogenetic analysis of new strains in the Guyana shelf (Guyana, Suriname, and French Guiana) Journal of Clinical Microbiology 42(5): 2020-2026
Pouliquen, J.-F.ço.; Hardy, L.; Lavergne, A.; Kafiludine, E.; Kazanji, M. 2004: High seroprevalence of human T-cell lymphotropic virus type 1 in blood donors in Guyana and molecular and phylogenetic analysis of new strains in the Guyana shelf (Guyana, Suriname, and French Guiana) Journal of Clinical Microbiology 42(5): 2020-2026
Nesic, Z.; Delic, D.; Prostran, M.; Vuckovic, S.; Stojanovic, R. 2002: Hepatitis G virus infection in individuals at high risk of transmission of viral hepatitis International Journal of Antimicrobial Agents 19(Suppl 1): S39
Mittal, A. 2003: High frequency of antibodies to syphilis and HIV in hepatitis C virus positive blood donors may reflect its sexual transmission in this region Sexually Transmitted Infections 79(2): 170-171
Ghebrekidan, H.; Cox, S.; Wahren, B.; Grandien, M. 1998: Prevalence of infection with HIV, hepatitis B and C viruses, in four high risk groups in Eritrea Clinical and Diagnostic Virology 9(1): 29-35
Tanwandee, T.; Piratvisuth, T.; Phornphutkul, K.; Mairiang, P.; Permpikul, P.; Poovorawan, Y. 2006: Risk factors of hepatitis C virus infection in blood donors in Thailand: a multicenter case-control study Journal of the Medical Association of Thailand 89(Suppl 5): S79-S83